CDC Website CDC Website

To Join the NPIN community or

Home » Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed)

Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites innovative research grant applications focused on identifying potential mechanisms and risk factors underlying HIV treatment associated neuropsychiatric symptoms and neurological toxicities experienced by some people living with HIV infection. Exploratory and high-risk research projects that may lead to identification of targets for therapeutic interventions or personalized medicine are appropriate for this FOA. Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 
 

Letter of Intent Date
4/2/19
Application Due Date
5/2/19
Project Start Date
12/1/19
Application Contact
Rita
Sisco
Lead/Supv Grants Management Specialist
United States
301-443-2805
siscor@mail.nih.gov
Technical Contact
Nick
Gaiano, Ph. D.
Chief, Extramural Review Branch
United States
301-827-3420
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Subjects
Audiences
Focus Area

Fund Number: 

5459

Fund ID: 

RFA-MH-20-115

Last Updated: 

3/1/19